title: Catatonia. 2: Diagnosis, management and prognosis.
abstract: This is the second of two articles reviewing catatonia. In the first, catatonia was described as an under-recognized syndrome with a potentially fatal outcome. It was suggested that treatment with neuroleptics may exacerbate the syndrome. The differential diagnosis, management and prognosis of catatonia are reviewed below.
authors.affiliation: Monyhull Hospital, Birmingham.
authors.forename: T
authors.initials: T
authors.lastname: Clark
authors.forename: H
authors.initials: H
authors.lastname: Rickards
mesh_terms: D001569:Benzodiazepines / Q000627:therapeutic use; D002389:Catatonia / Q000175:diagnosis* / Q000628:therapy*; D003937:Diagnosis, Differential; D004565:Electroconvulsive Therapy; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008140:Lorazepam / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis; D011379:Prognosis; D020230:Serotonin Syndrome / Q000175:diagnosis
chemical_list: D006993:Hypnotics and Sedatives; D001569:Benzodiazepines; D008140:Lorazepam